Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Return on Capital Employed (2021 - 2025)

Goldenwell Biotech's Return on Capital Employed history spans 4 years, with the latest figure at 0.28% for Q3 2025.

  • For Q3 2025, Return on Capital Employed changed N/A year-over-year to 0.28%; the TTM value through Sep 2025 reached 0.28%, changed N/A, while the annual FY2024 figure was 0.12%, N/A changed from the prior year.
  • Return on Capital Employed reached 0.28% in Q3 2025 per GWLL's latest filing, up from 0.26% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.28% in Q3 2025 to a low of 0.6% in Q2 2022.
  • Average Return on Capital Employed over 4 years is 0.1%, with a median of 0.06% recorded in 2021.
  • The largest YoY upside for Return on Capital Employed was -25bps in 2022 against a maximum downside of -25bps in 2022.
  • A 4-year view of Return on Capital Employed shows it stood at 0.07% in 2021, then plummeted by -297bps to 0.3% in 2022, then soared by 95bps to 0.02% in 2024, then skyrocketed by 1912bps to 0.28% in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Return on Capital Employed are 0.28% (Q3 2025), 0.26% (Q2 2025), and 0.02% (Q4 2024).